Minor histocompatibility antigen typing by DNA sequencing for clinical practice in hematopoietic stem-cell transplantation

Methods in Molecular Biology

Volumn 882, Issue , 2012, Pages 509-530

  Spierings, Eric ^a   Goulmy, Els ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genotyping, polymorphism, immunogenetics, immunotherapy; Graft versus host disease; Graft versus leukemia; Hematopoietic stem cell transplantation; Minor histocompatibility antigens

Indexed keywords

HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA B27 ANTIGEN; HLA B52 ANTIGEN; HLA B60 ANTIGEN; HLA B7 ANTIGEN; HLA B8 ANTIGEN; HLA DR15 ANTIGEN; HLA DRB3 ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

5' UNTRANSLATED REGION; ADOPTIVE TRANSFER; ALLELE; ARTICLE; CLINICAL PRACTICE; CODON; DNA SEQUENCE; ETHNIC GROUP; EXON; GENE FREQUENCY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOTHERAPY; LEUKEMIA REMISSION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURIFICATION; TISSUE DISTRIBUTION; VACCINATION; Y CHROMOSOME; GENETICS; HISTOCOMPATIBILITY TEST;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MINOR HISTOCOMPATIBILITY ANTIGENS; SEQUENCE ANALYSIS, DNA;

EID: 84867370133     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-842-9_29     Document Type: Article

References (70)

1. Goulmy E (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 157:125-140
2. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ (1976) Alloimmunity to human H-Y. Lancet 2:1206
3. Goulmy E, Bradley BA, Lansbergen Q, van Rood JJ (1978) The importance of H-Y incompatibility in human organ transplantation. Transplantation 25:315-319
4. Goulmy E, Gratama JW, Blokland E, Zwaan FE, van Rood JJ (1983) A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 302:159-161
5. van Els CA, D'Amaro J, Pool J, Blokland E, Bakker A, van Elsen PJ et al (1992) Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 35: 161-165
6. Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E et al (1995) Human H-Y: a male-speci fichistocompatibility antigen derived from the SMCY protein. Science 269:1588-1590
7. Goulmy E, Pool J, van den Elsen PJ (1995) Interindividual conservation of T-cell receptor beta chain variable regions by minor histocompatibility antigen-speci ficHLA-A*0201-restricted cytotoxic T-cell clones. Blood 85: 2478-2481
8. den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW et al (1995) Identi fication of a graft versus host diseaseassociated human minor histocompatibility antigen. Science 268:1476-1480
9. Verdijk RM, Kloosterman A, Pool J, Van De KM, Naipal AM, Van Halteren AG et al (2004) Pregnancy induces minor histocompatibility antigen-speci ficcytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 103:1961-1964
10. Mommaas B, Stegehuis-Kamp JA, Van Halteren AG, Kester M, Enczmann J, Wernet P et al (2004) Cord blood comprises antigenexperienced T cells speci ficfor maternal minor histocompatibility antigen HA-1. Blood 105: 1823-1827
11. Van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A et al (2009) Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 114: 2263-2272
12. Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J et al (2007) Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 3:e103
13. Gratwohl A, Hermans J, Niederwieser D, van Biezen A, van Houwelingen HC, Apperley J (2001) Female donors in fl uence transplantrelated mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J 2:363-370
14. Takami A, Sugimori C, Feng X, Yachie A, Kondo Y, Nishimura R et al (2004) Expansion and activation of minor histocompatibility antigen HY-speci ficT cells associated with graft-versus-leukemia response. Bone Marrow Transplant 34:703-709
15. de Bueger MM, Bakker A, Van Rood JJ, Van der Woude F, Goulmy E (1992) Tissue distribution of human minor histocompatibility antigens ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 149:1788-1794
16. Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN et al (2002) In situ dissection of the graft-versus-host activities of cytotoxic T cells speci ficfor minor histocompatibility antigens. Nat Med 8:410-414
17. Kim YH, Faaij CM, van Halteren AG, Schrama E, de Jong TA, Schøller J, Egeler RM, Pavel S, Vyth-Dreese FA, van Tol MJ, Goulmy E, Spierings E. In situ detection of HY-speci ficT cells in acute graft-versus-host disease-affected male skin after sex-mismatched stem cell transplantation. Biol Blood Marrow Transplant. 2012 Mar;18(3): 381-7. Epub 2011 Nov 4.
18. van der Harst D, Goulmy E, Falkenburg J, Kooij-Winkelaar Y, van Luxemburg-Heijs S, Goselink H et al (1994) Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 83:1060-1066
19. Marijt W, Heemskerk M, Kloosterboer F, Goulmy E, Kester M, van der Horn M et al (2003) Hematopoiesis-restricted minor histocompatibilty antigens HA-1-or HA-2-speci ficT cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 100:2742-2747
20. Kim YH, Vyth-Dreese FA, Schrama E, Pavel S, Bajema I, Goulmy E et al (2010) Exogenous addition of minor H antigen HA-1+ dendritic cells to skin tissues ex vivo causes infiltration and activation of HA-1 speci ficcytotoxic T cells. Biol Blood Marrow Transplant 17(1): 69-77
21. Mutis T, Goulmy E (2002) Hematopoietic system-speci ficantigens as targets for cellular immunotherapy of hematological malignancies. Semin Hematol 39:23-31
22. Klein CA, Wilke M, Pool J, Vermeulen C, Blokland E, Burghart E et al (2002) The hematopoietic system-speci ficminor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. J Exp Med 196:359-368
23. Fujii N, Hiraki A, Ikeda K, Ohmura Y, Nozaki I, Shinagawa K et al (2002) Expression of minor histocompatibility antigen, HA-1, in solid tumor cells. Transplantation 73: 1137-1141
24. Hambach L, Nijmeijer BA, Aghai Z, Schie ML, Wauben MH, Falkenburg JH et al (2006) Human cytotoxic T lymphocytes speci ficfor a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice. Leukemia 20:371-374
25. Hambach L, Vermeij M, Buser A, Aghai Z, Van der KT, Goulmy E (2008) Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors. Blood 112:1844-1852
26. Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E (1999) Feasibility of immunotherapy of relapsed leukemia with ex vivogenerated cytotoxic T lymphocytes speci ficfor hematopoietic system-restricted minor histocompatibility antigens. Blood 93:2336-2341
27. Mutis T, Ghoreschi K, Schrama E, Kamp J, Heemskerk M, Falkenburg JH et al (2002) Efficient induction of minor histocompatibility antigen HA-1-speci ficcytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA. Biol Blood Marrow Transplant 8:412-419
28. Oosten LE, Blokland E, Van Halteren AG, Curtsinger J, Mescher MF, Falkenburg JH et al (2004) Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-speci ficcytotoxic T lymphocytes. Blood 104:224-226
29. Heemskerk MH, Hoogeboom M, de Paus RA, Kester MG, van der Hoorn MA, Goulmy E et al (2003) Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-speci ficT-cell receptor complexes expressing a conserved alpha joining region. Blood 102:3530-3540
30. Mommaas B, Van Halteren AG, Pool J, Van V, Wieles B, Heemskerk MH et al (2005) Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer. Haematologica 90:1415-1421
31. Sadovnikova E, Jopling LA, Soo KS, Stauss HJ (1998) Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules. Eur J Immunol 28:193-200
32. Mutis T, Blokland E, Kester M, Schrama E, Goulmy E (2002) Generation of minor histocompatibility antigen HA-1-speci ficcytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation. Blood 100:547-552
33. Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al (2003) Hematopoiesis-restricted minor histocompatibility antigens HA-1-or HA-2-speci ficT cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 100:2742-2747
34. Kircher B, Stevanovic S, Urbanek M, Mitterschiffthaler A, Rammensee HG, Grunewald K et al (2002) Induction of HA-1-speci ficcytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion. Br J Haematol 117:935-939
35. Scheibenbogen C, Letsch A, Schmittel A, Asemissen AM, Thiel E, Keilholz U (2003) Rational peptide-based tumour vaccine development and T cell monitoring. Semin Cancer Biol 13:423-429
36. Figdor CG, de Vries I, Lesterhuis WJ, Melief CJ (2004) Dendritic cell immunotherapy: mapping the way. Nat Med 10:475-480
37. Hambach L, Aghai Z, Pool J, Kroger N, Goulmy E (2010) Peptide length extension skews the minor HA-1 antigen presentation toward activated dendritic cells but reduces its presentation efficiency. J Immunol 185: 4582-4589
38. Spierings E, Drabbels J, Hendriks M, Pool J, Spruyt-Gerritse M, Claas F et al (2006) A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS One 1:e42
39. Longo MC, Berninger MS, Hartley JL (1990) Use of uracil DNA glycosylase to control carryover contamination in polymerase chain reactions. Gene 93:125-128
40. Akatsuka Y, Nishida T, Kondo E, Miyazaki M, Taji H, Iida H et al (2003) Identi fication of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-speci ficminor histocompatibility antigens. J Exp Med 197: 1489-1500
41. Kawase T, Akatsuka Y, Torikai H, Morishima S, Oka A, Tsujimura A et al (2007) Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood 110:1055-1063
42. Tykodi SS, Fujii N, Vigneron N, Lu SM, Mito JK, Miranda MX et al (2008) C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients. Clin Cancer Res 14: 5260-5269
43. Spaapen RM, Lokhorst HM, Van de OK, Otterud BE, Dolstra H, Leppert MF et al (2008) Toward targeting B cell cancers with CD4+ CTLs: identi fication of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis. J Exp Med 205: 2863-2872
44. Torikai H, Akatsuka Y, Miyazaki M, Tsujimura A, Yatabe Y, Kawase T et al (2006) The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303. Br J Haematol 134:406-410
45. den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL et al (1998) The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279:1054-1057
46. Mommaas B, Kamp J, Drijfhout JW, Beekman N, Ossendorp F, Van Veelen P et al (2002) Identi fication of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. J Immunol 169: 3131-3136
47. Spierings E, Brickner AG, Caldwell JA, Zegveld S, Tatsis N, Blokland E et al (2003) The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 102:621-629
48. Brickner AG, Warren EH, Caldwell JA, Akatsuka Y, Golovina TN, Zarling AL et al (2001) The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 193:195-206
49. Dolstra H, Fredrix H, Maas F, Coulie PG, Brasseur F, Mensink E et al (1999) A human minor histocompatibility antigen speci ficfor B cell acute lymphoblastic leukemia. J Exp Med 189:301-308
50. Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T et al (2010) Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 115:4923-4933
51. van Bergen CA, Kester MG, Jedema I, Heemskerk MH, van Luxemburg-Heijs SA, Kloosterboer FM et al (2007) Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene. Blood 109:4089-4096
52. Van Bergen CA, Rutten CE, Van Der Meijden ED, Van Luxemburg-Heijs SA, Lurvink EG, Houwing-Duistermaat JJ et al (2010) Highthroughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res 70: 9073-9083
53. Stumpf AN, van der Meijden ED, van Bergen CA, Willemze R, Falkenburg JH, Griffioen M (2009) Identi fication of 4 new HLA-DRrestricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Blood 114:3684-3692
54. Griffioen M, van der Meijden ED, Slager EH, Honders MW, Rutten CE, van Luxemburg-Heijs SA et al (2008) Identi fication of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. Proc Natl Acad Sci USA 105: 3837-3842
55. de Rijke B, van Horssens-Zoetbrood A, Beekman JM, Otterrud B, Maas F, Woestenenk R et al (2005) A frame-shift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J Clin Invest 115: 3506-3516
56. Brickner AG, Evans AM, Mito JK, Xuereb SM, Feng X, Nishida T et al (2006) The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 107: 3779-3786
57. Kamei M, Nannya Y, Torikai H, Kawase T, Taura K, Inamoto Y et al (2009) HapMap scanning of novel human minor histocompatibility antigens. Blood 113:5041-5048
58. Warren EH, Gavin MA, Xuereb SM, Koo KK, Mito JK, Brown ML et al (2002) A single nucleotide polymorphism in the SP110 nuclear phosphoprotein gene creates a minor histocompatibility antigen whose expression is regulated by interferon-gamma. Blood 100:73A
59. Murata M, Warren EH, Riddell SR (2003) A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 197:1279-1289
60. Vogt MH, de Paus RA, Voogt PJ, Willemze R, Falkenburg JH (2000) DFFRY codes for a new human male-speci ficminor transplantation antigen involved in bone marrow graft rejection. Blood 95:1100-1105
61. Pierce RA, Field ED, den Haan JM, Caldwell JA, White FM, Marto JA et al (1999) Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identi fied by a novel mass spectrometric technique. J Immunol 163:6360-6364
62. Meadows L, Wang W, den Haan JM, Blokland E, Reinhardus C, Drijfhout JW et al (1997) The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modi fied cysteine that significantly affects T cell recognition. Immunity 6:273-281
63. Torikai H, Akatsuka Y, Miyazaki M, Warren EH, Oba T, Tsujimura K et al (2004) A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol 173:7046-7054
64. Rosinski KV, Fujii N, Mito JK, Koo KK, Xuereb SM, Sala-Torra O et al (2008) DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood 111: 4817-4826
65. Ivanov R, Aarts T, Hol S, Doornenbal A, Hagenbeek A, Petersen E et al (2005) Identi fication of a 40S ribosomal protein S4-derived H-Y epitope able to elicit
66. Vogt MH, Goulmy E, Kloosterboer FM, Blokland E, de Paus RA, Willemze R et al (2000) UTY gene codes for an HLA-B60-restricted human male-speci ficminor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 96:3126-3132
67. Warren EH, Gavin MA, Simpson E, Chandler P, Page DC, Disteche C et al (2000) The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol 164:2807-2814
68. Vogt MH, van den Muijsenberg J, Goulmy E, Spierings E, Kluck P, Kester M et al (2002) The DBY gene codes for an HLA-DQ5 restricted human male speci ficminor histocompatibility antigen involved in GvHD. Blood 99: 3027-3032
69. Zorn E, Miklos DB, Floyd BH, Mattes-Ritz A, Guo LX, Soiffer RJ et al (2004) Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 199: 1133-1142
70. Spierings E, Vermeulen C, Vogt MH, Doerner LEE, Falkenburg JHF, Mutis T et al (2003) Identi fication of HLA class II-restricted H-Yspeci ficT-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 362:610-615